Review
doi: 10.1111/j.1365-2265.1991.tb00299.x.
Management of prolactinomas
Affiliations
- PMID: 2036731
- DOI: 10.1111/j.1365-2265.1991.tb00299.x
Item in Clipboard
Review
Management of prolactinomas
Clin Endocrinol (Oxf).
1991 Mar.
Abstract
The management of prolactinomas requires a complex interaction of medical, surgical and radiotherapeutic intervention. With the judicious use of all these modalities, patients can usually be managed with great success and, perhaps more importantly, their presenting complaints (gonadal dysfunction and infertility) are usually completely corrected.
Similar articles
-
[Management of prolactinomas during pregnancy].Zhonghua Fu Chan Ke Za Zhi. 2002 Jun 18;37(6):335-7. Zhonghua Fu Chan Ke Za Zhi. 2002. PMID: 12126566 Chinese.
-
Prolactinomas: present day management.Br J Obstet Gynaecol. 1995 Mar;102(3):178-81. doi: 10.1111/j.1471-0528.1995.tb09090.x. Br J Obstet Gynaecol. 1995. PMID: 7794839 No abstract available.
-
Diagnosis and treatment of prolactinomas.Adv Intern Med. 1999;44:117-53. Adv Intern Med. 1999. PMID: 9929707 Review. No abstract available.
-
[The treatment of prolactinomas during pregnancy and the lactation period].Dtsch Med Wochenschr. 1996 Jan 5;121(1-2):28-32. doi: 10.1055/s-2008-1042968. Dtsch Med Wochenschr. 1996. PMID: 8565801 Review. German. No abstract available.
-
Contemporary management of prolactinomas.Neurosurg Focus. 2004 Apr 15;16(4):E2. doi: 10.3171/foc.2004.16.4.3. Neurosurg Focus. 2004. PMID: 15191331 Review.
Cited by
-
Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors.Mol Endocrinol. 2010 Mar;24(3):574-86. doi: 10.1210/me.2009-0369. Epub 2010 Feb 16. Mol Endocrinol. 2010. PMID: 20160122 Free PMC article.
-
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7961-5. doi: 10.1073/pnas.90.17.7961. Proc Natl Acad Sci U S A. 1993. PMID: 8367448 Free PMC article.
-
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.Br J Cancer. 1995 Dec;72(6):1397-9. doi: 10.1038/bjc.1995.520. Br J Cancer. 1995. PMID: 8519650 Free PMC article.
-
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization.Int J Mol Sci. 2023 Apr 4;24(7):6742. doi: 10.3390/ijms24076742. Int J Mol Sci. 2023. PMID: 37047716 Free PMC article. Review.
-
Prolactin secreting pituitary carcinoma.J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1205-6. doi: 10.1136/jnnp.55.12.1205. J Neurol Neurosurg Psychiatry. 1992. PMID: 1479402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
